Liu Yakun | Biochemistry | Best Innovation Award

Posted on by sciencefather

Dr. Liu Yakun | Biochemistry | Best Innovation Award

The Fourth Hospital of Hebei Med, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Liu YaKun earned a Doctor of Medicine degree from the prestigious Hebei Medical University. From the beginning of her academic journey, she displayed a deep commitment to women’s health and a strong passion for advancing clinical knowledge in gynecology. Her formative years were shaped by rigorous medical education, clinical rotations, and early exposure to research in gynecologic oncology.

💼 Professional Endeavors

Currently serving as the Associate Chief Physician at the Department of Gynecology, Fourth Hospital of Hebei Medical University, Dr. Liu also holds the significant position of Teaching Director. In this dual role, she combines her medical expertise with academic leadership, mentoring young doctors and medical students. Her clinical work is particularly focused on the diagnosis and surgical treatment of gynecologic tumors, and she is widely recognized for her meticulous approach and dedication to patient care.

🔬 Contributions and Research Focus

Dr. Liu’s primary research area lies in gynecologic tumors, especially ovarian malignancies. In a groundbreaking study, she and her team became the first in the world to identify a rare germline BMP15 mutation as a causative factor in hereditary ovarian immature teratoma (OIT). Through a combination of cell line experiments and animal models, the pathogenicity of this mutation was verified, significantly advancing the understanding of the etiology of OIT. This work not only provided a crucial biomarker for genetic screening but also paved the way for future studies on ovarian malignant germ cell tumors.

🌍 Impact and Influence

Dr. Liu’s discovery has had a global impact, offering new insights into rare gynecologic cancers and influencing genetic screening protocols worldwide. Her pioneering research has opened new avenues in oncology, particularly in the identification and treatment of hereditary tumors in women, thus contributing significantly to precision medicine in gynecology.

📚 Academic Citations and Recognition

As a first author, Dr. Liu has published numerous papers in SCI-indexed and core medical journals, contributing high-impact literature to the field. She has led multiple research projects and was honored with the First Prize of the Hebei Medical Science and Technology Award, underscoring her scientific excellence and clinical relevance.

🧪 Technical Skills

Dr. Liu is proficient in a wide range of clinical and laboratory techniques, including tumor marker analysis, surgical oncology procedures, molecular biology experiments, and animal model development. Her work seamlessly integrates clinical practice with laboratory research, enabling her to translate bench-side findings into bedside applications.

👩‍🏫 Teaching Experience

As the Teaching Director of her department, Dr. Liu is deeply involved in medical education and mentoring. She designs and delivers advanced training modules for residents and interns, oversees their clinical rotations, and encourages them to participate in research. Her teaching style is both inspiring and practical, often merging clinical scenarios with research discussions to foster comprehensive learning.

🌟 Legacy and Future Contributions

Dr. Liu YaKun’s legacy is being built on a foundation of clinical innovation, academic excellence, and compassionate care. She aims to further explore genetic mutations in gynecologic oncology, contribute to personalized medicine, and mentor the next generation of gynecologists. Her future work will likely continue to bridge the gap between clinical practice and genetic research, reinforcing her standing as a trailblazer in women’s health.

📖Notable Publications

New insights into the ferroptosis and immune infiltration in endometriosis: a bioinformatics-based analysis

Authors: Lusha Liu, Feifei Han, Naiyi Du, Yakun Liu, Aihong Duan, Shan Kang, Bin Li
Journal: Frontiers in Immunology
Year: 2025

Incorporating genotype information in a precise prediction model for platinum sensitivity in epithelial ovarian cancer

Authors: Nai-Yi Du, Yan Li, Hui Zheng, Ya-Kun Liu, Lu-Sha Liu, Jianbang Xie, Shan Kang
Journal: Frontiers in Oncology
Year: 2025

Stratifin (SFN) Regulates Cervical Cancer Cell Proliferation, Apoptosis, and Cytoskeletal Remodeling and Metastasis Progression Through LIMK2/Cofilin Signaling

Authors: Naiyi Du, Daojuan Li, Wei Zhao, Yakun Liu
Journal: Molecular Biotechnology
Year: 2024

The Diagnostic Significance of Combined Screening and Human Papillomavirus 16 and 18 Cycle Threshold Values for CIN2+ Cervical Lesions

Authors: Xue Bai, Ya-Kun Liu, Ya-Jing Jia, Dao-Juan Li, Nai-Yi Du
Journal: International Journal of Women’s Health
Year: 2024

Causal effects of genetically determined circulating metabolites on endometriosis: A Mendelian randomization study

Authors: Lusha Liu, Junping Yin, Yakun Liu, Bin Li, Shan Kang, Naiyi Du
Journal: Medicine
Year: 2024

LIMK1 promotes the development of cervical cancer by up-regulating the ROS/Src-FAK/cofilin signaling pathway

Authors: Yajing Jia, Yongping Li, Naiyi Du, Wei Zhao, Yakun Liu
Journal: Aging
Year: 2024

Fei Yao | Biochemistry | Best Researcher Award

Posted on by sciencefather

Prof. Fei Yao | Biochemistry | Best Researcher Award

The First Affiliated Hospital of Guangxi Medical University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Prof. Fei Yao’s journey in academia began with a strong foundation in biochemistry and medical sciences. With a keen interest in cancer biology, Prof. Yao pursued higher education in oncology, eventually earning a medical degree and further advancing into postdoctoral research. This rigorous academic training laid the groundwork for future contributions to cancer research.

🏥 Professional Endeavors

Currently serving as a Professor of Oncology at The First Affiliated Hospital of Guangxi Medical University, China, and The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Prof. Yao has seamlessly integrated clinical expertise with research innovations. As a medical doctor and postdoctoral fellow, Prof. Yao also mentors master’s students, shaping the next generation of researchers in oncology and biochemistry.

🔬 Contributions and Research Focus

Prof. Yao’s research primarily focuses on tumor microenvironment mechanisms and the development of clinical drugs for cancer treatment. By leading multiple prestigious research projects funded by:

  • 🏅 National Natural Science Foundation of China
  • 🏅 China Postdoctoral Science Foundation
  • 🏅 Guangxi Natural Science Foundation

Prof. Yao has significantly contributed to understanding how cancer cells interact with their surroundings, paving the way for novel therapeutic strategies.

📚 Impact and Influence

Prof. Yao has published multiple SCI-indexed research papers, adding valuable insights to the field of oncology and biochemistry. These studies have not only been widely cited but have also influenced clinical applications and drug development in cancer research.

📖 Academic Citations & Recognition

With a robust research portfolio, Prof. Yao’s work has been cited extensively in international journals, reinforcing its scientific impact. These contributions continue to shape the landscape of cancer treatment and personalized medicine.

🛠️ Technical Skills & Expertise

Prof. Yao possesses expertise in various advanced biochemical and clinical research techniques, including:
✔️ Tumor Microenvironment Analysis
✔️ Cell Culture & Molecular Biology Techniques
✔️ Targeted Drug Development for Cancer
✔️ Clinical Trials & Experimental Therapies
✔️ Biostatistical Analysis & Research Methodologies

🎓 Teaching and Mentorship

As a Master’s Supervisor, Prof. Yao plays a crucial role in mentoring graduate students, guiding them in research methodologies, experimental designs, and thesis development. Many students have benefited from this mentorship, progressing in their careers as medical researchers and clinicians.

🌎 Legacy and Future Contributions

With a deep commitment to advancing cancer research, Prof. Yao aims to:
🔹 Continue exploring innovative treatments targeting the tumor microenvironment.
🔹 Bridge the gap between traditional Chinese medicine and modern oncology.
🔹 Develop next-generation clinical drugs to improve patient outcomes.
🔹 Inspire young researchers to contribute meaningfully to biochemistry and oncology.

🏆 Conclusion

Prof. Fei Yao’s dedication to biochemistry and cancer research has established a remarkable legacy in oncology, drug development, and clinical applications. As an esteemed professor, researcher, and mentor, Prof. Yao’s contributions will continue to impact the field for years to come.

📖Notable Publications

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients

Authors: L. Zhong, L. Gan, B. Wang, W. Shi, Y. Zhao

Journal: Cell

Year: 2025

Biao Cheng | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Biao Cheng | Molecular Biology | Best Researcher Award 

General Hospital of Southern Theater Command, Guangzhou, China

👨‍🎓Profiles

📚 Early Academic Pursuits

Biao Cheng embarked on his academic journey with a strong foundation in medical sciences, focusing on dermatology, plastic surgery, and regenerative medicine. His early research revolved around wound healing mechanisms and innovative therapeutic approaches. With a keen interest in advancing medical treatments, he dedicated himself to understanding platelet-derived products and their applications in skin tissue repair. His academic pursuits laid the groundwork for significant contributions to regenerative medicine, particularly in developing standardized methods for platelet concentrate preparation.

🏥 Professional Endeavors

As a Professor and Chief Director at the Dermatology Hospital, Southern Medical University, and the Department of Burn and Plastic Surgery at the General Hospital of Southern Theater Command, Cheng has been at the forefront of advancements in burn treatment, trauma care, and tissue regeneration. His extensive research in platelet concentrates and regenerative medicine has had a profound impact on clinical practices, improving patient outcomes. He has led various pioneering projects aimed at optimizing platelet-derived therapies and their applications in reconstructive and aesthetic medicine, bridging the gap between research and real-world medical treatments.

🔬 Contributions and Research Focus

Cheng’s research primarily centers on wound healing, platelet-derived therapies, and burn treatment, with a particular emphasis on regenerative medicine. He has played a crucial role in developing standardized platelet concentrate preparation techniques, which have become essential in clinical applications. His work has led to the creation of innovative biomaterials, such as antibacterial composite scaffolds and rolling injection devices, designed to enhance wound healing, even under extreme conditions. His research has not only contributed to scientific advancements but has also been instrumental in improving medical interventions for trauma and burn patients.

🌍 Impact and Influence

With a citation index of 29, Cheng’s contributions have gained widespread recognition in the fields of dermatology, plastic surgery, and regenerative medicine. His research findings have been published in esteemed journals, including Wound Repair and Regeneration, British Journal of Dermatology, and Stem Cells and Development, shaping the direction of modern wound healing treatments. His extensive body of work has influenced both academic research and clinical applications, making him a prominent figure in the field of regenerative medicine.

📖 Academic Contributions

Cheng has made significant contributions to medical literature through his authorship of several authoritative books. His works, including 《Platelet-Rich Plasma in Tissue Repair and Regeneration》, 《Growth Factors and Skin Tissue Repair》, and 《Guidelines for the Regenerative and Rehabilitation Applications of Concentrated Platelets》, serve as valuable references for researchers and medical practitioners alike. These publications provide critical insights into the applications of platelet-derived therapies and growth factors in tissue repair and regeneration, further advancing knowledge in the field.

🛠️ Technical Skills

Cheng possesses extensive expertise in a range of advanced medical technologies. His proficiency includes Platelet-Rich Plasma (PRP) and Growth Factor Therapies, Stem Cell-Based Regenerative Medicine, Intelligent Negative Pressure Wound Therapy, and the Development of Advanced Biomaterials for Wound Healing. His technical skills have been instrumental in developing novel therapeutic solutions for skin tissue repair, trauma treatment, and aesthetic medicine. His contributions to medical technology continue to push the boundaries of innovation in regenerative medicine.

🎓 Teaching and Mentorship

As a dedicated educator, Cheng has played a pivotal role in mentoring students and young researchers in tissue engineering, plastic surgery, and regenerative medicine. His guidance has helped shape the careers of numerous medical professionals, ensuring the continuity of innovative research in the field. Beyond the classroom, he actively participates in national and international medical conferences, sharing his knowledge and insights with the broader medical community. His commitment to teaching extends to training programs, where he equips medical practitioners with the latest advancements in regenerative treatments.

🏆 Legacy and Future Contributions

Cheng’s ongoing research and contributions continue to shape the future of regenerative medicine. His commitment to developing next-generation wound healing solutions and standardizing concentrated platelet products for clinical use remains a driving force in the field. His vision for the future includes further refining regenerative medicine techniques to improve their efficacy in aesthetic and reconstructive surgery. As an active member of leading medical committees and a reviewer for top dermatologic journals, he plays a vital role in shaping policies and guiding research directions in tissue repair and regenerative medicine. His legacy will be defined by his groundbreaking contributions, ensuring that innovative medical treatments reach a broader spectrum of clinical applications.

📖Notable Publications

Innate lymphoid cell-based immunomodulatory hydrogel microspheres containing Cutibacterium acnes extracellular vesicles for the treatment of psoriasis

Authors: Xu Yujie, Gan Yuyang, Qi Fangfang, Hu Zhiqi, Wang Gaofeng

Journal: Acta Biomaterialia

Year: 2024

Luminescence-activated Pt(IV) prodrug for in situ triggerable cancer therapy

Authors: An Huijie, Yang Chen, Jiang Zhihui, Liu Hongjiang, Yu Zhiqiang

Journal: Chinese Chemical Letters

Year: 2024

Antibacterial Antimicrobial Peptide Grafted HA/SF/Alg Wound Dressing Containing AIEgens for Infected Wound Treating

Authors: Lin Yize, Tan Yan, Deng Rong, Cheng Biao, Chen Yi

Journal: ACS Omega

Year: 2024

Transconjunctival Fat Repositioning Blepharoplasty: Is Excess Fat Herniation a Prerequisite?

Authors: Chen Jianwu, Wu Yanhong, Wang Yuzhi, Huang Wenhua, Cheng Biao

Journal: Plastic and Reconstructive Surgery

Year: 2024

Clinical efficacy of blood derivatives on wound healing: A systematic review and network meta-analysis

Authors: Wu Yanhong, Peng Guang, Wang Yuzhi, Tang Jianbing, Cheng Biao

Journal: International Wound Journal

Year: 2024

The Role of Stem Cells on Wound Healing After Revascularization—Healing Following Revascularization—Unlocking Skin Potential

Authors: Cheng Biao, Fu Xiaobing

Journal: The International Journal of Lower Extremity Wounds

Year: 2024

 

 

Hwayeon Sun | Probiotic | Young Scientist Award

Posted on by sciencefather

Dr. Hwayeon Sun | Probiotic | Young Scientist Award

Soonchunhyang University, South Korea

👨‍🎓Profile

🌱 Early Academic Pursuits

Hwayeon Sun’s academic journey began with a Bachelor of Arts in Art History from Myoung-ji University in Seoul, Republic of Korea, completed in 2013. With a passion for interdisciplinary studies, She later pursued a Master’s degree in Biomedical Science at Soonchunhyang University, specializing in Urology and Family Medicine, with a research focus on the role of Ginsenoside Rg3 in tumor apoptosis. Building upon this foundation, She completed a Ph.D. in Interdisciplinary Biomedical Science, investigating the psychological impacts on medical personnel during the COVID-19 pandemic, guided by Professor Byung-wook Yoo.

👩‍🔬 Professional Endeavors

In a career spanning over nine years, She has established expertise in clinical research. Currently, at Pharmsville Co., Ltd.’s Microbiome R&D Center, She contributes to projects focused on the development of functional health products, including muscle function improvement using Lactobacillus and joint health enhancement through medicinal mushroom complexes. Her prior role as a Clinical Research Coordinator at Soonchunhyang University Hospital involved managing study protocols, patient selection, and regulatory documentation for global clinical trials across phases 2, 3, and 4.

🔬 Contributions and Research Focus

Her research spans various medical fields, such as diabetes, hypertension, cardiovascular health, and COVID-19 vaccine testing. At Pharmsville, Hwayeon contributed to projects aimed at enhancing cognitive and immune health through functional foods derived from Korean fermented products. Additionally, Hwayeon has been involved in marketing consultations for probiotic products and contributed as both first and co-author to 17 SCI-level publications.

🌍 Impact and Influence

With expertise in diverse health conditions and extensive involvement in clinical trials, Her research has contributed to the advancement of therapeutic products in both national and international contexts. The successful commercialization of health products, such as those enhancing cognitive function and immunity, reflects Hwayeon’s commitment to translating research findings into practical health solutions.

📚 Academic Cites

Her work is cited in SCI-level journals, with 17 publications where Hwayeon is a co-author and five as a first author, showcasing the researcher’s contributions to clinical methodologies and therapeutic studies in biomedical science.

🛠️ Technical Skills

She is proficient in MS Office Suite, R Software (R Studio), SPSS, Cube CDMS, iMedidata, and electronic medical records (EMR). This technical proficiency supports Hwayeon's ability to document, analyze, and report on complex clinical data, making she adaptable and efficient in various research environments.

👩‍🏫 Teaching Experience

Although specific teaching experience isn't detailed, She has contributed extensively to internal team training and compliance with research protocols. This involves educating study participants and coordinating with medical staff, highlighting Her communication skills and knowledge-sharing abilities within clinical research.

🏆 Legacy

Her commitment to advancing clinical research has positioned them as a valuable contributor to both academic knowledge and practical health solutions. Her legacy is marked by the development of functional health products and rigorous adherence to regulatory standards, influencing future research in microbiome and probiotic therapeutics.

🔮 Future Contributions

She is poised to continue contributing to research on microbiome-based health interventions and chronic disease management, especially in the context of functional foods. Future endeavors may involve further exploration of fermented products and their potential applications in preventive healthcare. Hwayeon's ongoing work promises to impact public health through innovative research and product development.

📖Notable Publications

Authors: Hwa Yeon Sun, Sangmin Park, Jiye Mok, 정현 서, Nicole Lee, Byungwook Yoo
Journal: Foods
Year: 2024

Authors: Hwa Yeon Sun, Jinyoung Shin, MinJi Kim, Sunghwan Bae, Nicole Lee, Byungwook Yoo
Journal: Journal of Clinical Medicine
Year: 2024